Home
About Us
Technology
Pipeline
Our Pipelines
our Pipelines
ALT001
ALT002
ALT003
Focus
Focus Areas
Amyotrophic Lateral Sclerosis
Alzheimer’s disease
Stroke Recovery
Autism Spectrum Disorder
Mitochondrial Diseases
Cerebral Small Vessel Disease
Hemiplegia
Traumatic Brain Injury
Multiple System Atrophy
News
Contact
中文版
中文版
news & articles
Innovation In
Focus Stories
From Lab.
Beijing Darwincell Biotech Debuts at the 2025 NEALS Meeting, Showcasing New Progress in ALS Therapeutics
Caring for the Elderly, Safeguarding Memory – Alzheimer’s Disease Science-Popularization Open Day Successfully Held — DarwinCell Biotech Alzheimer’s Disease Public Science Open Day
DarwinCell Showcases novel MSC-based drug ALT001 at the 150th American Neurological Association Annual Meeting
DARWINCELL
Darwin Biotech Chairwoman Yu Wang Named “Beijing March 8th Red-Banner Holder”: Illuminating New Hope for Life Through Science
DARWINCELL
30 days ago
Darwin's "DEW003" Initiates Clinical Trials for Alzheimer's Disease
DARWINCELL
30 days ago
Beijing TianTan Hospital Establishes Center for Rare Neurological Diseases, Ushering in a New Era of Diagnosis and Treatment
DARWINCELL
30 days ago
Darwin Biotech and Beijing TianTan Hospital to Advance Research on Rare Neurological Diseases